Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$113.24 - $131.95 $33,405 - $38,925
-295 Reduced 14.29%
1,769 $233,000
Q3 2023

Nov 02, 2023

SELL
$102.95 - $114.33 $15,442 - $17,149
-150 Reduced 6.78%
2,064 $212,000
Q2 2023

Jul 24, 2023

SELL
$108.61 - $118.38 $109,370 - $119,208
-1,007 Reduced 31.26%
2,214 $255,000
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $54,558 - $60,875
-530 Reduced 14.13%
3,221 $342,000
Q4 2022

Jan 27, 2023

SELL
$87.44 - $112.11 $127,400 - $163,344
-1,457 Reduced 27.98%
3,751 $0
Q3 2022

Nov 01, 2022

SELL
$84.53 - $94.96 $26,880 - $30,197
-318 Reduced 5.75%
5,208 $449,000
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $6,261 - $7,098
-75 Reduced 1.34%
5,526 $504,000
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $35,505 - $39,799
-483 Reduced 7.94%
5,601 $460,000
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $30,679 - $33,739
-428 Reduced 6.57%
6,084 $457,000
Q2 2021

Jul 29, 2021

SELL
$70.31 - $77.77 $33,959 - $37,562
-483 Reduced 6.9%
6,512 $506,000
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $10,329 - $12,166
-150 Reduced 2.1%
6,995 $539,000
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $23,124 - $26,212
-316 Reduced 4.24%
7,145 $593,000
Q4 2019

Jan 29, 2020

SELL
$77.58 - $87.54 $47,168 - $53,224
-608 Reduced 7.54%
7,461 $679,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $24,986 - $28,996
383 Added 4.98%
8,069 $617,000
Q2 2018

Aug 02, 2018

SELL
$50.83 - $59.72 $10,166 - $11,944
-200 Reduced 2.54%
7,686 $467,000
Q1 2018

Apr 25, 2018

SELL
$50.96 - $59.23 $10,192 - $11,846
-200 Reduced 2.47%
7,886 $430,000
Q3 2017

Oct 30, 2017

BUY
$58.67 - $63.13 $474,405 - $510,469
8,086
8,086 $518,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.